MHP-Net: A Revolutionary AI Model for Accurate Liver Tumor Segmentation for Diagnosis and Therapy

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the disease, but manual segmentation by radiologists is labor-intensive and often results in variations based on expertise. Artificial intelligence (AI)-based tumor segmentation models have revolutionized tumor assessment in medical imaging - using deep convolutional neural networks, they identify and outline the exact shape, size, and location of a tumor in a medical scan image. But their efficacy comes with a heavy dependence on large volumes of data (typically ranging from 1,000 to 10,000 cases). This requirement for big data is a major barrier in medical AI.

To overcome this barrier, a team of researchers led by Professor Kenji Suzuki and a PhD student, Yuqiao Yang, from the Biomedical AI Research Unit of Institute of Science Tokyo (Science Tokyo), Japan, has developed a groundbreaking AI model that can accurately segment liver tumors from computed tomography (CT) scans - even when trained using extremely small datasets - surpassing the performance of current state-of-the-art systems. Their study was published in Volume 13 of the journal IEEE Access on May 16, 2025.

At the heart of this innovation is a novel architecture called the multi-scale Hessian-enhanced patch-based neural network (MHP-Net). MHP-Net works by breaking medical images into small 3D image patches - so the AI can focus on one part at a time rather than the entire image. It then pairs each patch from the original CT image with a corresponding enhanced version, achieved through a technique called Hessian filtering. Hessian filtering helps highlight spherical objects such as tumors in the image.

The result is a high-resolution tumor segmentation map that accurately delineates liver tumors from contrast-enhanced CT scans. To evaluate the model’s performance, the team used the "Dice similarity score," which compares how well the predicted segmentation matches the ground truth (usually annotated by expert radiologists) on a scale of 0 to 1.

"Despite a limited training set of 7, 14, and 28 tumors, we achieved high performance dice scores of 0.691, 0.709, and 0.719, respectively," notes Suzuki. "With these scores, our model surpasses major established models such as U-Net, Res U-Net, and HDense-U-Net."

Apart from its promising performance, the lightweight architecture of the model allows for fast training (under 10 minutes) and real-time inference (~4 seconds per patient), making it highly suitable for use even in clinical settings with limited computational resources.

"This is just a start in the field of small-data AI, where meaningful and clinically relevant deep learning models can be built from limited datasets." Says Suzuki. "MHP-Net's success can inspire small-data AI solutions in other areas of medical imaging as well, such as the detection of rare cancers."

The study marks the potential of small-data AI in medical image analysis. By lowering the threshold for the data required for training, MHP-Net democratizes the use of AI in medical image analysis, especially in under-resourced hospitals and clinics with limited access to data. In the future, the researchers plan to explore broader applications of the small-data AI models - enabling scalable, cost-effective, and versatile deployment of AI in healthcare worldwide.

Yang Y, Sato M, Jin Z, Suzuki K.
Patch-based Deep-learning Model with Limited Training Dataset for Liver Tumor Segmentation in Contrast-enhanced Hepatic Computed Tomography.
IEEE Access. 2025. doi: 10.1109/ACCESS.2025.3570728

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...

AI Detects Hidden Heart Disease Using Ex…

Mass General Brigham researchers have developed a new AI tool in collaboration with the United States Department of Veterans Affairs (VA) to probe through previously collected CT scans and identify...

Groundbreaking TACIT Algorithm Offers Ne…

Researchers at VCU Massey Comprehensive Cancer Center have developed a novel algorithm that could provide a revolutionary tool for determining the best options for patients - both in the treatment...

Highland Marketing Announced as Official…

Highland Marketing has been named, for the second year running, the official communications partner for HETT Show 2025, the UK's leading digital health conference and exhibition. Taking place 7-8 October...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...